CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/03/2023
Voltar para busca
Dado oficial do USPTO
I-MED PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
77
Atualização mais recente
06/03/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
3, 5, 10
Data de depósito
01/07/2017
Data de registro
18/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/10/2022
Última transação
18/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Primeiro uso
31/12/2017
Primeiro uso no comércio
31/12/2017
Código do desenho
3
Tipo de titular
03
Localização do titular
Dollard-des Ormeaux, CA
Examinador
CALLOWAY, CHRISTINA DENISE
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "I-MED" positioned above the wording "PHARMA" and a stylized liquid drop design to the left to the wording.
Titulares e representantes
Titulares
I-MED PHARMA INC.
Representantes
James R Menker HOLLEY & MENKER, PA
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
eye gels; non-medicated eye washes
Classe 5
Pharmaceutical preparations for use in ophthalmology; eye drops; medicated eye washes; cleaninghydrating and disinfecting solutions for medical instruments for ophthalmic use; ophthalmic pharmaceutical preparationssolutions for use in surgery; nutritional supplements for the health of the eye
Classe 10
Surgical instruments and devices; Eye care productseye droppers for human and veterinary use and eye protectors for therapeutic use for treating dry eyes for human and veterinary use; surgical instruments; Prosthetic intraocular lens implants; medical devices for diagnosing ophthalmic diseasesdisorders and conditions; medical devices for measuring intraocular pressure; medical devices for measuring osmolarity of eye tissues; surgical devices and machines for performing ophthalmic surgery; operating room customized surgical packs containing surgical instruments and surgical supplies for ophthalmic surgery
Publicações
Histórico de despachos e eventos da marca no USPTO.
77 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/03/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/03/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
18/10/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
14/09/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2022
PUBO
PUBLISHED FOR OPPOSITION
05/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/06/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
31/05/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
27/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/04/2022
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
11/04/2022
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
11/04/2022
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
11/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/03/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
17/10/2021
GNFR
FINAL REFUSAL E-MAILED
17/10/2021
CNFR
FINAL REFUSAL WRITTEN
17/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2021
GNRT
NON-FINAL ACTION E-MAILED
12/09/2021
CNRT
NON-FINAL ACTION WRITTEN
12/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/02/2021
GNRT
NON-FINAL ACTION E-MAILED
25/02/2021
CNRT
NON-FINAL ACTION WRITTEN
25/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/02/2021
ALIE
ASSIGNED TO LIE
18/02/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/02/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
09/02/2021
IUAA
USE AMENDMENT ACCEPTED
07/02/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
14/01/2021
IUAF
USE AMENDMENT FILED
14/01/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
13/01/2021
DMCC
DATA MODIFICATION COMPLETED
23/12/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/11/2020
GNSL
LETTER OF SUSPENSION E-MAILED
12/11/2020
CNSL
SUSPENSION LETTER WRITTEN
12/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/10/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/10/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
21/05/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
21/11/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
21/05/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
15/11/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/05/2018
GNSL
LETTER OF SUSPENSION E-MAILED
11/05/2018
CNSL
SUSPENSION LETTER WRITTEN
11/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/04/2018
ALIE
ASSIGNED TO LIE
19/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/10/2017
GNRT
NON-FINAL ACTION E-MAILED
16/10/2017
CNRT
NON-FINAL ACTION WRITTEN
16/10/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/09/2017
GNRT
NON-FINAL ACTION E-MAILED
29/09/2017
CNRT
NON-FINAL ACTION WRITTEN
29/09/2017
DOCK
ASSIGNED TO EXAMINER
27/09/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2017
NWAP
NEW APPLICATION ENTERED
05/07/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace I-MED PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.